ClinicalTrials.Veeva

Menu

Effects of Training Dose on Computerized Cognitive Training in Patients With Cognitive Impairment

Capital Medical University logo

Capital Medical University

Status

Completed

Conditions

Cognitive Impairment, Mild
Dementia

Treatments

Other: Computerized cognitive training with different training doses

Study type

Observational

Funder types

Other

Identifiers

NCT05922319
2023027

Details and patient eligibility

About

The goal of this observational study is to explore the optimal dose of computerized cognitive training in patients with cognitive impairment. The main questions it aims to answer are:

  • Is there an optimal dose of computerized cognitive training for patients with cognitive impairment?
  • Is the optimal dose different in patients in different age populations? Participants enrolled in the study took a reported computerized cognitive training program and the training data were analyzed for exploring the optimal dose.

The researchers will compare the different dose groups to see if there is an optimal dose for the highest improvement in cognitive abilities.

The researchers will additionally compare two age groups (aged younger than 60y or aged 60y and older) to see if the optimal doses in the two groups are different.

Full description

Background: Computerized Cognitive Training (CCT) is a form of digital therapeutics that uses computerized cognitive tasks to train patients with cognitive impairment caused by various neurological or psychiatric diseases. CCT has been shown to slow the progression of cognitive impairment in early-stage dementia, particularly in working memory. However, there is a lack of research on the optimal training dose for people with cognitive impairment. Previous meta-analyses have explored the types, delivery methods, and training dose of cognitive training in healthy older adults and those with dementia risk factors, but not in those with cognitive impairment.

Objectives: The study aimed to explore the dose-response relationship of CCT and estimate the optimal daily and weekly dose for people with cognitive impairment.

Participants and methods: the study is a retrospective cohort study and will enroll 21845 patients with cognitive impairment. The exposures in the study are different doses of cognitive training in a week and the outcome is the improvement in cognitive abilities in a week. The weeks with the same training dose of different patients will be classified into one group of exposure. The mixed effects model will be used to estimate the optimal dose.

Enrollment

21,845 patients

Sex

All

Ages

40 to 100 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients with cognitive impairment.
  • Patients who took computerized cognitive training in 2017-2022.
  • age ≥ 40 years
  • Training duration ≥ 2 weeks

Exclusion criteria

  • with moderate to severe dementia, cancer, unstable systemic diseases, or psychiatric diseases

Trial design

21,845 participants in 1 patient group

Patients with cognitive impairment taking computerized cognitive training
Description:
The exposures and outcomes were measured repeatedly during the training process for each patient. The outcomes were compared to assess the effect of different exposures (computerized cognitive training with different doses). A mixed effects model was built to solve the random effects of patients.
Treatment:
Other: Computerized cognitive training with different training doses

Trial contacts and locations

1

Loading...

Central trial contact

Yi Tang, M.D., Ph.D.; Yi Xing, M.D.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems